Beta 1-integrin-mediated cell signaling in T lymphocytes

Journal of Dermatological Science

Volumn 23, Issue 2, 2000, Pages 75-86

  Iwata, Satoshi ^a   Ohashi, Yoshiyuki ^a   Kamiguchi, Kenjiro ^a   Morimoto, Chikao ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

1 integrins; p130Cas (Crk associated substrate); Paxillin; pp105Cas L; pp125FAK (focal adhesion kinase); Tyrosine phosphorylation; VLA proteins

Indexed keywords

BETA1 INTEGRIN; CELL ADHESION MOLECULE; FIBRONECTIN; FOCAL ADHESION KINASE; GLUTATHIONE TRANSFERASE; INTEGRIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PAXILLIN; PHOSPHOLIPASE C; T LYMPHOCYTE RECEPTOR; VERY LATE ACTIVATION ANTIGEN;

CELL ADHESION; HUMAN; IMMUNOBLOTTING; LEUKEMIA CELL LINE; LYMPHOCYTE PROLIFERATION; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

ANIMALS; ANTIGENS, CD29; HUMANS; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0034212943     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(99)00096-1     Document Type: Review

References (50)

1. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 69:1992;11-25.
2. Schwartz M.A., Lechene C., Ingber D.E. Insoluble fibronectin activates the Na/H antiporter by clustering and immobilizing integrin alpha 5 beta 1, independent of cell shape. Proc. Natl. Acad. Sci. USA. 88:1991;7849-7853.
3. Shattil S.J., Brugge J.S. Protein tyrosine phosphorylation and the adhesive functions of platelets. Curr. Opin. Cell. Biol. 3:1991;869-879.
4. Sultan C., Plantavid M., Bachelot C., Grondin P., Breton M., Mauco G., Levy T.S., Caen J.P., Chap H. Involvement of platelet glycoprotein Iib-IIIa (alpha Iib-beta 3 integrin) in thrombin-induced synthesis of phosphatidylinositol 3′,4′-bisphosphate. J. Biol. Chem. 266:1991;23554-23557.
5. Matsuyama T., Yamada A., Kay J., Yamada K.M., Akiyama S.K., Schlossman S.F., Morimoto C. Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex. J. Exp. Med. 170:1989;1133-1148.
6. Masuyama J., Berman J.S., Cruikshank W.W., Morimoto C., Center D.M. Evidence for recent as well as long term activation of T-cells migrating through endothelial cell monolayers in vitro. J. Immunol. 148:1992;1367-1374.
7. Nojima Y., Humphries M.J., Mould A.P., Komoriya A., Yamada K.M., Schlossman S.F., Morimoto C. VLA-4 mediates CD3-dependent CD4+ T-cell activation via the CS1 alternatively spliced domain of fibronectin. J. Exp. Med. 172:1990;1185-1192.
8. Yamada A., Nojima Y., Sugita K., Dang N.H., Schlossman S.F., Morimoto C. Cross-linking of VLA/CD29 molecule has a co-mitogenic effect with anti-CD3 on CD4 cell activation in serum-free culture system. Eur. J. Immunol. 21:1991;319-325.
9. Yamada A., Nikaido T., Nojima Y., Schlossman S.F., Morimoto C. Activation of human CD4 T lymphocytes. Interaction of fibronectin with VLA-5 receptor on CD4 cells induces the AP-1 transcription factor. J. Immunol. 146:1991;53-56.
10. Salomon D.R., Mojcik C.F., Chang A.C., Wadsworth S., Adams D.H., Coligan J.E., Shevach E.M. Constitutive activation of integrin alpha 4 beta 1 defines a unique stage of human thymocyte development. J. Exp. Med. 179:1994;1573-1584.
11. Williams D.A., Rios M., Stephens C., Patel V.P. Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature (London). 352:1991;438-441.
12. Edward M. Integrins and other adhesion molecules involved in melanocytic tumor progression. Curr. Opin. Oncol. 7:1995;185-191.
13. Danen E.H., Van Muijen G.N., Ruiter D.J. Role of integrins as signal transducing cell adhesion molecules in human cutaneous melanoma. Cancer Survey. 24:1995;43-65.
14. De Luca M., Pellegrini G., Zambruno G., Marchisio P.C. Role of integrins in cell adhesion and polarity in normal keratinocytes and human skin pathologies. J. Dermatol. 21:1994;821-828.
15. Bata-Csorgo X., Hammerberg C., Voorhees J.J., Cooper K.D. Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia. J. Invest. Dermatol. 105:1995;895-945.
16. Santamaria Babi L.F., Perez Soler M.T., Hauser C., Blaser K. Skin-homing T-cells in human cutaneous allergic inflammation. Immunol. Res. 14:1995;317-324.
17. Nojima Y., Rothstein D.M., Sugita K., Schlossman S.F., Morimoto C. Ligation of VLA-4 on T-cells stimulates tyrosine phosphorylation of a 105-kD protein. J. Exp. Med. 175:1992;1045-1053.
18. Sato T., Tachibana K., Nojima Y., D'Avirro N., Morimoto C. Role of the VLA-4 molecule in T-cell costimulation. Identification of the tyrosine phosphorylation pattern induced by the ligation of VLA-4. J. Immunol. 155:1995;2938-2947.
19. Nojima Y., Tachibana T., Sato T., Schlossman S.F., Morimoto C. Focal adhesion kinase (pp125FAK) is tyrosine-phosphorylated after engagement of α4β1 and α5β1-integrins on human T-lymphoblastic cells. Cell. Immunol. 161:1995;8-13.
20. Minegishi M., Tachibana K., Sato T., Iwata S., Nojima Y., Morimoto C. Structure and function of Cas-L, a 105-kD Crk-associated substrate-related protein that is involved in beta 1-integrin-mediated signaling in lymphocytes. J. Exp. Med. 184:1996;1365-1375.
21. Tachibana K., Sato T., D'Avirro N., Morimoto C. Direct association of pp125FAK with paxillin, the focal adhesion- targeting mechanism of pp125FAK. J. Exp. Med. 182:1995;1089-1099.
22. Polte T.R., Hanks S.K. Interaction between focal adhesion kinase and Crk-associated tyrosine kinase substrate p130Cas. Proc. Natl. Acad. Sci. USA. 92:1995;10678-10682.
23. Songyang Z., Shoelson S.E., Chaudhuri M., Gish G., Pawson T., Haser W.G., King F., Roberts T., Ratnofsky S., Lechleider R.J., Neel B.G., Raymond R.B., Fajardo J.E., Chou M.M., Hanafusa H., Schaffhausen B., Cantley L.C. SH2 domains recognize specific phosphopeptide sequences. Cell. 72:1993;767-778.
24. Ishino M., Ohba T., Sasaki H., Sasaki T. Molecular cloning of a cDNA encoding a phosphoprotein, Efs, which contains a Src homology 3 domain and associates with Fyn. Oncogene. 11:1995;2331-2338.
25. Sakai R., Iwamatsu A., Hirano N., Ogawa S., Tanaka T., Mano H., Yazaki Y., Hirai H. A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. Eur. Mol. Biol. Organ J. 13:1994;3748-3756.
26. Tachibana K., Urano T., Fujita H., Ohashi Y., Kamiguchi K., Iwata S., Hirai H., Morimoto C. Tyrosine phosphorylation of Crk-associated substrates by focal adhesion kinase: a putative mechanism for the integrin-mediated tyrosine phosphorylation of Crk-associated substrates. J. Biol. Chem. 272:1997;29083-29090.
27. Ohashi Y., Tachibana K., Kamiguchi K., Fujita H., Morimoto C. T-cell receptor-mediated tyrosine phosphorylation of Cas-L, a 105kDa Crk-associated substrate-related protein, and its association of Crk and C3G. J. Biol. Chem. 273:1998;6446-6451.
28. Tanaka S., Morishita T., Hashimoto Y., Hattori S., Nakamura S., Shibuya M., Matuoka K., Takenawa T., Kurata T., Nagashima K., Mastuda M. C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins. Proc. Natl. Acad. Sci. USA. 91:1994;3443-3447.
29. Gotoh T., Hattori S., Nakamura S., Kitayama H., Noda M., Takai Y., Kaibushi K., Matsui H., Hatase O., Takahashi H., Kurata T., Mastuda M. Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G. Mol. Cell. Biol. 15:1995;6746-6753.
30. Udagwa T., Woodside D.G., McIntyre B.W. α4β1 (CD49d/CD29) integrin costimulation of human T-cells enhances transcription factor and cytokine induction in the absence of altered sensitivity to anti-CD3 stimulation. J. Immunol. 157:1996;1965-1972.
31. Ennis E., Isberg R.R., Shimizu Y. Very late antigen 4-dependent adhesion and costimulation of resting human T-cells by the bacterial beta 1-integrin ligand invasin. J. Exp. Med. 177:1993;207-212.
32. Kamiguchi K, Tachibana K, Iwata S, Ohashi Y, Morimoto C. Cas-L is required for β1-integrin-mediated costimulation in human T-cells. J Immunol 1999; 163: 563-568.
33. Law S.F., Estojak J., Wang B., Mysliwiec T., Kruh G., Golemis E.A. Human enhancer of filamentation 1, a novel p130cas-like docking protein, associates with focal adhesion kinase and induces pseudohyphal growth in Saccharomyces cerevisiae. Mol. Cell. Biol. 16:1996;3327-3337.
34. Weiss A., Littman D.R. Signal transduction by lymphocyte antigen receptors. Cell. 76:1994;263-274.
35. Wange R.L., Samelson L.E. Complex complexes: signaling at the TCR. Immunity. 5:1996;197-205.
36. Ribon V., Satiel A.R. Nerve growth factor stimulates the tyrosine phosphorylation of endogenous Crk-II and augments its association with p130Cas in PC-12 cells. J. Biol. Chem. 13:1996;7375-7380.
37. Schraw W., Richmond A. Melanoma growth stimulatory activity signaling through the class II interleukin-8 receptor enhances the tyrosine phosphorylation of Crk-associated substrate, p130, and a 70-kilodalton protein. Biochemistry. 34:1995;13760-13767.
38. Ingham R.J., Krebs D.L., Barbazuk S.M., Turck C.W., Hirai H., Matsuda M., Gold M.R. B cell antigen receptor signaling induces the formation of complexes containing the Crk adapter proteins. J. Biol. Chem. 50:1996;32306-32314.
39. Manie S.N., Beck A.R., Astier A., Law S.F., Canty T., Hirai H., Drucker B.J., Avraham H., Haghayeghi N., Sattler M., Salgia R., Griffin J.D., Golemis E.A., Freedman A.S. The related adhesion focal tyrosine kinase differentially phosphorylates p130Cas and the Cas-like protein, p105HEF1. J. Biol. Chem. 272:1997;4230-4236.
40. Schlaepfer D.D., Broome M.A., Hunter T. Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins. Mol. Cell. Biol. 17:1997;1702-1713.
41. Alexandropoulos K., Baltimore D. Coordinate activation of c-Src by SH3- and SH2 binding sites on a novel p130Cas-related protein, Sin. Genes Dev. 10:1996;1341-1355.
42. Hasegawa H., Kiyokawa E., Tanaka S., Nagashima K., Gotoh N., Shibuya M., Kurata T., Matsuda M. DOCK180, a major CRK-binding protein, alters cell morphology upon translocation to the cell membrane. Mol. Cell. Biol. 16:1996;1770-1776.
43. Feller S.M., Knudsen B., Hanafusa H. Cellular proteins binding to the first Src homology 3 (SH3) domain of the proto-oncogene product c-Crk indicate Crk-specific signaling pathways. Oncogene. 10:1995;1465-1473.
44. Ren R., Ye Z.S., Baltimore D. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes Dev. 8:1994;783-795.
45. Kitayama H., Sugimoto Y., Matsuzaki T., Ikawa Y., Noda M. A ras-related gene with transformation suppressor activity. Cell. 56:1989;77-84.
46. Hu C.D., Kariya K., Shirouzu M., Yokoyama S., Kataoka T. Coassociation of Rap1A and Ha-Ras with Raf-1 N-terminal region interferes with ras-dependent activation of Raf-1. J. Biol. Chem. 272:1997;11702-11705.
47. Tanaka S., Ouchi T., Hanafusa H. Downstream of Crk adaptor signaling pathway: activation of Jun kinase by v-Crk through the guanine nucleotide exchange protein C3G. Proc. Natl. Acad. Sci. USA. 94:1997;2356-2361.
48. Su B., Jacinto E., Hibi M., Kallunki T., Karin M., Ben-Neriah Y. JNK is involved in signal integration during costimulation of T lymphocytes. Cell. 77:1994;727-736.
49. Bennett A.M., Hausdorff S.F., O'Reilly A.M., Freeman R.M., Neel B.G. Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression. Mol. Cell. Biol. 16:1996;1189-1202.
50. Owaki H., Varma R., Gillis B., Bruder J.T., Rapp U.R., Davis L.S., Geppert T.D. Eur. Mol. Biol. Organ J. 12:1993;4367-4373.